- Premium Stock Alerts
- Posts
- Pre-Market Gems! Don't Miss Out!
Pre-Market Gems! Don't Miss Out!
Noor Saba
March 26, 2024
Don’t want emails from us anymore? Click here to unsubscribe
Hello Part-time Trader…👋
Premium Stock Alerts is here with your pre-market cheat sheet. In today's issue, we delve into:
Fed's Latest Announcements: Understand the Federal Reserve's recent decisions and economic outlook, and how they might influence the markets.
Volume Anomalies: Identify stocks witnessing unusual trading volumes, pointing to potential opportunities or risks.
Top Pre-Market Movers: Identify early winners poised for a strong market opening.
Market Indices & Sector Overview: Get a snapshot of key market indices and sector performances to gauge the day's potential trends.
FDA Approvals & Upcoming Decisions: Keep an eye on the latest FDA approvals and crucial upcoming decisions affecting biotech and pharmaceutical stocks.
Now, let's dive into today's edition for a closer look at the insights and analysis that will shape your trading decisions.
Sponsored
$200 Trillion "AI Phase 2" Moments Away?
"AI Phase 2" is on course to mint 2,931 millionaires every single day...
And if you click here now, you'll see how YOU could get a piece of the action...
Happening Today
✓ 08:30 AM ET – Durable Goods Orders (MoM) (Feb)
✓ 09:00 AM ET – S&P/CS HPI Composite - 20 n.s.a. (YoY) (Jan)
✓ 09:00 AM ET – S&P/CS HPI Composite - 20 n.s.a. (MoM) (Jan)
✓ 10:00 AM ET – CB Consumer Confidence (Mar)
PREMARKET SNAPSHOT 📈
Stock markets dip: Dow leads the decline with a 0.41% drop.
S&P500$5,218.19 ⬇️ -0.31% | Dow$39,313.64 ⬇️ -0.41% | NASDAQ$16,384.47 ⬇️ -0.27% |
SECTOR SNAPSHOT ✨
Most sectors down today, Energy (+0.91%) and Utilities (+0.46%) lead the gainers.
NAME | PRICE | %CHANGE |
|---|---|---|
Consumer Discretionary | 1,471.97 | -0.21% 🔴 |
Consumer Staples | 804.58 | -0.27% 🔴 |
Energy | 712.08 | +0.91% 🟢 |
Financials | 687.54 | -0.29% 🔴 |
Health Care | 1,694.13 | -0.16% 🔴 |
Industrials | 1,053.05 | -0.68% 🔴 |
Materials | 575.98 | +0.03% 🟢 |
Real Estate | 241.73 | -0.42% 🔴 |
Information Technology | 3,849.92 | -0.52% 🔴 |
Communication Services | 285.45 | -0.35% 🔴 |
Utilities | 325.83 | +0.46% 🟢 |
Sponsored
The Only Stock You Need To Buy Now
Don't miss out on this stock. As powerful as it is, the move could be soon and fast. Also get a sneak peek at the system generating these huge winners.
Get This Top Stock Ready To Move Now
Unusual Volume
📈 Next.e.GO N.V. (EGOX) jumped 29.52% to $0.05 on a whopping 292.84 million shares traded. The company received delisting notice from Nasdaq.
📈 Investors went wild, sending KULR Technology Group Inc (KULR) stock soaring 55.55% to $0.33 on a massive volume of 126.48 million shares.
📈 Abnormal activity shook Altamira Therapeutics Ltd (CYTO), pushing it up 35.84% to $2.35 on a whopping 62.81 million shares traded after announcing collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines.
📈 SINTX Technologies Inc (SINT) stock recently closed -45.95% lower at $0.05 on substantial volume of 52.69 million shares. The company recently announced pricing of $1.3 million public offering of common stock.
📈 Ocugen Inc (OCGN) increase by 11.59% in a single trading session, with abnormally high trading volume of 44.07 million shares.
Sponsored
Unlock Prosperity: 5 Must-Buy Stocks for Elite Wealth Growth!
Discover the wealth-building power of the market! Our financial gurus unveil 5 exclusive stocks poised for exceptional growth. Act now to join the ranks of savvy investors. Tap into success - your opportunity awaits!
Click for privileged access!
Premarket Movers
C3is Inc. (CISS) experiences a substantial 16.48% surge in pre-market trading ahead of fourth quarter and twelve months 2023 financial and operating results.
Greenwave Technology Solutions, Inc. (GWAV) sees a significant 19.01% increase, reaching a pre-market price of $0.18 after announcing that Dominion Energy is currently in the process of connecting its second automotive shredder to the power grid which is expected to be completed by March 29, 2024.
Salarius Pharmaceuticals, Inc. (SLRX) demonstrates a noteworthy 54.40% surge, with a pre-market price of $2.98. The company announced a definitive Business Combination Agreement with Nobul AI Corp. under which the shareholders of Nobul will become the majority holders of the combined company.
Pre Market Gainers | Pre Market Change | Pre Market Volume |
|---|---|---|
CISS | +16.48% | 52.06M |
GWAV | +19.01% | 4.17M |
CHEK | +54.40% | 1.95M |
OPGN | +35.60% | 1.45M |
INTJ | +4.66% | 770.35K |
STOK | +92.15% | 704.68K |
WKHS | +6.76% | 388.96K |
FFIE | +4.73% | 256.00K |
RDDT | +6.24% | 213.28K |
VKTX | +8.41% | 184.17K |
Sponsored
The 10 Best AI Stocks to Own NOW - Yours FREE
If you've been following the AI revolution, there's a chance you can guess who's #1 on my brand new list of the best AI stocks to own (if you are lucky, you may even own some shares of this powerhouse already). But I doubt you can guess who's #3 on the list. (HINT: It delivers a technology that's critical to the AI revolution and will soon be embedded in countless consumer products.)
You'll be surprised by some of the names on the list! Learn the names of all 10 stocks here FREE
Important FDA
Recently Announced
Orchard Therapeutics (ORTX) received FDA approval for its gene therapy to treat metachromatic leukodystrophy in children (on March 18th).
OptiNose (OPTN) received FDA approval for its XHANCE nasal spray to treat chronic rhinosinusitis in adults (on March 15th).
Upcoming this Week
Merck (MRK) awaits FDA verdict on Sotatercept for pulmonary arterial hypertension in adults (decision on March 26th).
Akebia Therapeutics (AKBA) anticipates FDA decision on Vadadustat for treating anemia in chronic kidney disease (decision on March 27th).
🎁 Looking for More? Check out these complementary newsletters for diverse perspectives:
|
Happy investing,
Maeve Grace
Editor In Cheif
Premium Trade Alerts
Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.
Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.
Reply